Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirofiban in Elderly Acute Cerebral Infarction
ChiCTR2500115199Phase 4Recruiting
- Sponsor
- Hengzhou People's Hospital
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tirofiban in ischemic stroke and brain infarction (2 arms), sponsored by Hengzhou People's Hospital. Primary endpoints: Proportion of patients with mRS score ≤2 at 90 days and Improvement rate of NIHSS score within 90 days (reduction ≥4 points). Started Dec 2025; status: recruiting.
02
Drugs
tirofiban
03
Conditions
ischemic strokebrain infarction
Beyond the preview
Go deeper on ChiCTR2500115199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500115199.